Dietmar Berger, new Gilead Sciences CMO
December 13, 2024 06:38 AM ESTUpdated 08:27 AM
People

Gilead names Di­et­mar Berg­er CMO as it eyes R&D re­set

Ayisha Sharma

News Reporter

Gilead Sci­ences has tapped Sanofi’s Di­et­mar Berg­er as its next chief med­ical of­fi­cer in a bid to shake up its strat­e­gy at the tail end …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ed­i­tas to cut 65% of work­force, of­fi­cial­ly stops work on ex vi­vo sick­le cell ther­a­py

Xaira hires for­mer Roche ex­ec as CMO; 'Tis the sea­son for re­tire­ments at Al­ny­lam, Re­gen­eron

Af­ter poor lung can­cer da­ta, iTeos drops in­u­padenant to dou­ble down on TIG­IT

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

Safe­ty con­cerns and tri­al holds for pe­di­atric RSV vac­cines prompt cau­tion from FDA ad­comm

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times